U.S. Gas Utilities Stock News

Recently, Surgery Partners reduced its earnings guidance after encountering slower surgical case growth, a less favorable payer mix, and reimbursement pressures across its facilities. An important angle is that the company is still prioritizing higher-acuity procedures and robotics investments, suggesting a focus on reshaping its case mix despite these operational challenges. We’ll now explore how this guidance cut, driven by slower case growth and payer mix headwinds, affects Surgery...

Medpace Holdings (MEDP) has followed up its recent run of strong results with Q4 2025 revenue of US$708.5 million and basic EPS of US$4.78, backing that up with trailing 12 month revenue of about US$2.5 billion and EPS of US$15.64. Over recent quarters the company has seen revenue move from US$533.3 million in Q3 2024 to US$708.5 million in Q4 2025, while quarterly basic EPS has ranged from US$3.11 to US$4.78 across the same stretch. With trailing net profit margins at 17.8% versus 19.2% the...

Mesabi Trust (MSB) has put fresh FY 2026 numbers on the table, with third quarter revenue of US$3.6 million, basic EPS of US$0.21 and net income of US$2.8 million. The trust has seen quarterly revenue move between US$4.7 million and US$6.9 million and EPS range from US$0.28 to US$0.46 over the past year of reported periods, alongside net income between US$3.6 million and US$6.1 million. This sets a clear context for the latest print. With a trailing net margin of 82.8% and earnings quality...

Farmers & Merchants Bancorp (FMAO) has put fresh numbers on the board, with Q4 2025 revenue of about US$31.9 million and basic EPS of US$0.70, supported by net income of US$9.7 million as the latest marker ahead of its Q1 2026 reporting period. The business has seen revenue move from US$26.6 million and EPS of US$0.59 in Q4 2024 to US$31.9 million and EPS of US$0.70 in Q4 2025. Trailing 12 month earnings growth of 29.4% and a 27.6% net margin frame a profitability profile that many investors...

Southern Missouri Bancorp (SMBC) opened Q3 2026 with Q2 results that put revenue and earnings in clear focus, reporting total revenue of US$48.0 million and basic EPS of US$1.62 on net income of US$18.1 million. The company has seen revenue move from US$41.7 million with EPS of US$1.10 in Q1 2025 to US$45.1 million and EPS of US$1.40 in Q4 2025, then to US$48.0 million and EPS of US$1.62 in Q2 2026. This latest report can be viewed as part of a steady earnings story that investors can now...

Carter Bankshares (CARE) opened Q1 2026 reporting Total Revenue of US$42.1 million in Q4 2025 and Basic EPS of US$0.38, with trailing twelve month EPS at US$1.38 and net income of US$31.0 million framing the latest run rate. Over the past year, Total Revenue on a trailing basis has moved from US$140.9 million to US$157.1 million while Basic EPS has shifted from US$1.06 to US$1.38, alongside earnings growth of 27.7% and net profit margin stepping up from 17.2% to 19.7%. For investors, these...

Republic Bancorp (RBCA.A) set the tone for Q1 2026 with recent results that sit against a trailing twelve month backdrop of US$385.9 million in revenue and basic EPS of US$6.65, underpinned by net income of US$131.3 million. Over the last few quarters, revenue has ranged from US$76.6 million to US$118.2 million per quarter while basic EPS moved between US$0.97 and US$2.40, giving investors a clear view of how the top and bottom lines have trended into the latest release. With a 34% net profit...

ONE Gas (OGS) has drawn fresh attention after its recent trading session, with the stock closing at $88.76. For investors, the move brings added focus to how the regulated utility’s fundamentals line up. See our latest analysis for ONE Gas. The latest move to $88.76 comes after a 14.93% 90 day share price return and a 16.97% total shareholder return over the past year, hinting that momentum has been building rather than fading. If this kind of steady utility performance has you thinking about...

MarineMax (HZO) has just posted its latest quarterly results, with Q1 2026 revenue of US$505.2 million and a basic EPS loss of US$0.36, alongside same store sales growth of 10.7%. The company has reported revenue of US$563.1 million in Q4 2024, US$631.5 million in Q2 2025, US$657.2 million in Q3 2025, US$552.2 million in Q4 2025, and US$505.2 million in Q1 2026, while EPS has ranged from a profit of US$0.80 in Q1 2025 to a loss of US$2.42 in Q3 2025. Margins remain under pressure, so this...

Thermo Fisher Scientific (TMO) has just put fresh numbers on the table, with Q4 2025 revenue of US$12.2b and basic EPS of US$5.22 setting the tone against a trailing twelve month EPS of US$17.78 on revenue of US$44.6b, alongside net income of US$6.7b. The company has seen quarterly revenue move from US$10.6b in Q3 2024 to US$12.2b in Q4 2025, while basic EPS over the same period went from US$4.27 to US$5.22. This gives investors a clear read on top line scale and earnings power as they assess...

Kearny Financial (KRNY) has just reported Q3 2026 results with quarterly revenue in the low US$40 million range and basic EPS of about US$0.15, set against a trailing twelve month EPS of US$0.52 that reflects the shift back into profitability. Over recent periods, revenue has moved from US$36.96 million in Q1 2025 to US$42.97 million in Q2 2026, while quarterly EPS has stepped from roughly US$0.10 to just over US$0.15. This gives investors a clearer read on how earnings now sit relative to...

First Bancorp (FBNC) opened 2026 with Q1 results that put the focus squarely on the income statement, reporting total revenue of US$119.2 million and basic EPS of US$1.13, backed by trailing twelve month revenue of US$393.3 million and EPS of US$2.93. Over recent periods the company has seen quarterly revenue move from US$65.2 million in Q4 2024 to US$104.7 million in Q1 2025, US$108.8 million in Q2, US$86.2 million in Q3 and US$79.2 million in Q4, while EPS shifted from US$0.09 to US$0.88,...

Investors may be wondering if Bristol-Myers Squibb at around US$59 a share still offers value, or if most of the opportunity is already priced in. The stock has returned 0.1% over the past week, 2.8% over the past month, 10.4% year to date and 27.3% over the last year, which naturally raises questions about what is currently baked into expectations. Recent attention on large pharmaceutical names, including Bristol-Myers Squibb, has centered on their pipelines, patent cycles and the role of...

Why Monolithic Power Systems Stock Is Back in Focus Ahead of Earnings Investor attention around Monolithic Power Systems (MPWR) has picked up as the company approaches its next quarterly report, following upbeat Q4 2025 results and positive guidance for Q1 2026 revenue of US$770 million to US$790 million. See our latest analysis for Monolithic Power Systems. The recent enthusiasm around earnings has coincided with strong momentum, with a 30 day share price return of 44.53% and a 1 year total...

Belite Bio recently initiated a rolling New Drug Application submission to the U.S. FDA for tinlarebant, an investigational oral therapy for Stargardt disease type 1, following completion of a Phase 3 trial and multiple regulatory designations including Breakthrough Therapy and Orphan Drug status. This step positions tinlarebant as a potential first approved treatment for Stargardt disease and highlights Belite Bio’s advancing regulatory and commercialization plans in rare retinal...

Northrim BanCorp (NRIM) opened 2026 with Q1 results anchored by a loan book of US$2.4b and a net interest margin of 4.77%, setting the tone for how its earnings engine is currently running. Over recent quarters, the bank has seen total revenue range from US$42.7m in Q4 2024 to US$64.9m in Q3 2025, while trailing twelve month net income reached US$64.6m, giving investors a clear view of how profits are tracking into the new year. With a cost to income ratio of 61.81% in Q1 2026 and non...

Visa Stock Snapshot After Recent Price Moves Visa (V) has seen mixed share performance recently, with a 1 day return of about a 1% decline, a 2% decline over the past week, and a small positive move over the past month. Over the past 3 months, the stock shows roughly a 5% decline and the year to date return is about an 11% decline, while the 1 year total return is about a 7% decline for investors holding through this period. See our latest analysis for Visa. Visa’s recent share price...

In April 2026, Teradata Corporation announced that its enterprise-grade Analyst Agent became available on Microsoft Marketplace, giving Azure customers a no-code, conversational analytics tool that orchestrates complex SQL queries and visualizations within their existing Teradata and Azure environments. A distinctive feature of this launch is Teradata’s Agent Telemetry, which makes the AI agent’s reasoning observable and auditable, allowing enterprises to configure custom quality signals and...

Knight-Swift Transportation Holdings (KNX) Q1 2026 Earnings Snapshot Knight-Swift Transportation Holdings (KNX) heads into Q1 2026 on the back of Q4 2025 revenue of US$1,856.3 million and a basic EPS loss of US$0.04, with trailing 12 month basic EPS at US$0.41 on total revenue of about US$7.5 billion. The company has seen quarterly revenue move in a tight band between US$1,824.4 million and US$1,927.1 million over the past year, while basic EPS ranged from a loss of US$0.04 in Q4 2025 to a...

Roku (ROKU) is back in focus after a strong six month run, outpacing the S&P 500. The stock has drawn renewed attention alongside solid quarterly results, higher streaming hours, improving free cash flow margin, and growing interest ahead of upcoming earnings. See our latest analysis for Roku. The recent 30 day share price return of 20.26% and a 1 year total shareholder return of 77.82% suggest momentum has been building, although the 5 year total shareholder return of a 67.77% loss shows...

Dover (DOV) kicked off Q1 2026 against a backdrop of recent quarterly revenue between US$1.87 billion and US$2.10 billion and basic EPS ranging from US$1.74 to US$2.21 through 2025, with trailing 12 month revenue at about US$8.09 billion and EPS at US$8.01. Over that same trailing period, revenue has stayed in a tight band around US$7.72 billion to US$8.09 billion, while EPS moved between US$7.55 and US$8.01. This provides a clear sense of how top line and per share earnings have been...

Targa Resources Corp. recently approved a 25% increase in its quarterly cash dividend to US$1.25 per share, or US$5.00 annually, for the first quarter of 2026, payable on May 15 to shareholders of record as of April 30. This step, consistent with earlier guidance, highlights how management is using higher cash returns to signal confidence in the business ahead of its upcoming earnings release. Next, we’ll examine how this 25% dividend increase interacts with Targa’s growth investments and...

Earlier this month, Amentum Holdings appointed Joseph (Joe) DeNardi as Senior Vice President and Head of Investor Relations, while also highlighting its role in providing critical ground systems operations and recovery support for NASA’s crewed Artemis II mission. The combination of a new investor relations leader with deep sector expertise and Amentum’s hands-on contribution to Artemis II underscores the company’s focus on both capital markets engagement and complex, mission-critical space...

Wondering whether ESCO Technologies at around US$318.83 still offers value, or if most of the opportunity is already reflected in the price. The stock has posted returns of 6.3% over the last week, 15.2% over the past month, 61.3% year to date and 102.2% over the past year, with a 3 year return of 242.0% and 5 year return of 190.3%. Recent coverage has focused on ESCO Technologies as a capital goods player whose share price performance has drawn fresh attention from investors seeking quality...